CD4 and laryngeal carcinoma: Finally, we evaluated the effects of DCs that were cocultured with oxaliplatin-treated primary laryngeal cancer cells on the populations of T cells, including IFN-γ-producing CD8+ T cells and CD4+CD25+FoxP3+ Treg cells.